Introduction
Proliferation, dierentiation, as well as prevention of apoptosis in hematopoietic cells require the functions of cytokines such as granulocyte/macrophage colony stimulating factor (GM ± CSF) and interleukin-3 (IL-3) (Steelman et al., 1996; May, 1997; Johnson, 1998; McCubrey et al., 1998; Blalock et al., 1999; Mangi and Newland, 1999; Ogawa and Matsunaga, 1999; Blagosklonny, 2000; Hoyle et al., 2000; Moye et al., 2000) . Cytokines can induce various signal transduction pathways that transduce critical growth and/or dierentiation signals from the cell membranes into the nucleus. One signal transduction pathway that can be activated by such cytokines in hematopoietic cells is the Ras/Raf/MEK/ERK pathway (Dent et al., 1998; Hibi and Hirano, 1998; Blalock et al., 1999; Frank, 1999; Lee, 1999; Hoyle et al., 2000; McCubrey et al., 2000; Moye et al., 2000) . So far, three Raf genes have been identi®ed in mammalian cells; they are Raf-1, ARaf and B-Raf (Fukui et al., 1987; Sithanandam et al., 1990; Daum et al., 1994; Lee et al., 1994) . The Raf proteins have three conserved domains: CR1, CR2 and CR3. The CR1 region contains the binding site for an activated Ras protein. The CR3 region contains the Raf kinase domain which is negatively regulated by the CR2 domain (Stanton et al., 1989; Heidecker et al., 1990; Vojtek et al., 1993; Brtva et al., 1995; Marshall, 1995; Drugan et al., 1996; Morisset et al., 1999) .
The individual functions of these three dierent Raf proteins are not fully understood. It was shown that all three Raf genes are activated by oncogenic Ras (Jelinek et al., 1996; Kuroda et al., 1996; Marais et al., 1997; Voice et al., 1999; Yamamoto et al., 1999; Weber et al., 2000) , target the same downstream molecules, i.e. MEK-1 and MEK-2 (Pritchard et al., 1995; Reuter et al., 1995; Hagemann and Rapp, 1999; Sutor et al., 1999; Kwon et al., 2000) , and use the same 14-3-3 adapter proteins for conformational stabilization and activation (Fantl et al., 1994; Freed et al., 1994; Irie et al., 1994; Papin et al., 1996; Tazivion et al., 1998; Hagemann and Rapp, 1999) . However, dierent biological and biochemical properties among them have been reported and their functions are non-compensatable (Marais et al., 1995; Muszynski et al., 1995; Pritchard et al., 1995) . For instance, the distribution of Raf proteins in mice is very dierent. The Raf-1 protein is expressed ubiquitously in almost all tissues examined while ARaf is predominately expressed in urogenital tissues and B-Raf in the neuronal tissues (Storm et al., 1990; Wadewitz et al., 1993) . Knockout mice with deletion of the dierent Raf genes have revealed very dierent phenotypes (Pritchard et al., 1995 (Pritchard et al., , 1996 Wojnowski et al., 1997 Wojnowski et al., , 1998 . A signi®cant dierence in their ability to phosphorylate MEK-1 molecules was reported in that B-Raf has the highest activity, which is 10-fold higher than Raf-1 and 500-fold higher than A-Raf (Pritchard et al., 1995) . In addition, in murine cells the kinase activities of both Raf-1 and A-Raf were stimulated by Ras and Src. However, B-Raf kinase activity was controlled by Ras and other members of the small G protein family such as Rap1 in PC12 cells (Vossler et al., 1997) or TC21 in NIH3T3 cells (Marias et al., 1997; Rosario et al., 1999) .
Previously, we have shown that aberrant activation of Raf could lead to the abrogation of cytokinedependency and the prevention of apoptosis in murine and human hematopoietic cells and dierent Raf proteins varied in their ability to induce cytokineindependency (McCubrey et al., 1998; Hoyle et al., 2000) . FDC-P1 cells and other hematopoietic cells such as TF-1 express all three Raf proteins and their kinase activity is induced after cytokine treatment (McCubrey et al., 1998; Sutor et al., 1999) . In this study, we further investigated the mechanism of cell proliferation induced by aberrant activation of Raf genes using b-estradiol-responsive murine hematopoietic FDC-P1 clonal cell lines. These cell clones were obtained by infecting the parental FDC-P1 cells with DRaf:ER retroviral constructs . In these DRaf:ER constructs, both the CR1 and CR2 domains of Raf proteins were removed and the truncated Raf proteins were fused with the hormonebinding domain of estrogen receptor protein (Samuels et al., 1993; Bosch et al., 1997) . The strategy of using DRaf:ER fusion proteins to study the functions of dierent Rafs was ®rst developed by Dr Martin McMahon's group in 1993 (Samuels et al., 1993; Pritchard et al., 1995) . Since the CR1 Ras binding domain was deleted from these Raf constructs, they cannot bind with Ras on the cell membrane to transduce signaling initiated by IL-3. Since the CR2 negative regulatory domain was also deleted and the remaining CR3 Raf kinase domain was fused with an estrogen-binding domain of the estrogen receptor, these DRaf:ER fusion proteins become active upon b-estradiol treatment.
IL-3 can activate Ras/Raf/MEK/ERK pathway as well as other pathways including PI3K/Akt, STAT/ JAK and RalGEF/Ral pathways. The purpose of using the DRaf:ER model is to speci®cally activate the Raf/MEK/ERK pathway and study its function. After IL-3 binds with IL-3 receptor on cell membrane, the Shc protein becomes associated with the distal end of the b c -chain. Shc recruits the GTP exchange complex Grb2/Sos resulting the loading of membrane bound Ras with GTP. Ras:GTP then recruits Raf to the membrane where it becomes activated. Activated Raf can then phosphorylate and activate its downstream target MEK and therefore activate Raf/MEK/ERK pathway. The strategy we used is to speci®cally activate Raf/MEK/ERK pathway by b-estradiol. DRaf:ERs have been shown to activate the downstream targets of Raf molecule, MEK-1 and MEK-2 as well as ERK1 and ERK2 (McCubrey et al., 1998; Hoyle et al., 2000) . It is therefore suggested as a good model for the investigation of Raf/MEK/ERK signaling pathway. In the following study, we have investigated the eects of these conditional Raf genes on cell cycle progression.
Results

Ectopic activation of the three DRaf oncoproteins and their downstream target MEK-1 in Raf-responsive hematopoietic cells
To examine the expression of DRaf:ER kinases in the Raf-responsive FD cells, the cells were deprived of bestradiol for 24 h and then b-estradiol was added back to activate the DRaf:ER. After 24 h of starvation, the DRaf:ER kinase activity was reduced to moderate levels in both FD/DRaf-1:ER and FD/DB-Raf:ER cells (Figure 1a,c) , whereas no Raf kinase activity was detected in FD/DA-Raf:ER cells (Figure 1b) . When the cells were treated with b-estradiol, the DRaf:ER activity was induced within 12 h and continually increased in FD/DA-Raf:ER cells (Figure 1b As a control, to determine the levels of DRaf:ER proteins present in the kinase assays, the kinase blots were immunoblotted with the aER antibody. We reproducibly detected higher levels of DRaf:ER proteins in FD/DA-Raf:ER than in either FD/DRaf-1:ER or FD/DB-Raf:ER cells. However, even though there were more DRaf:ER proteins detected in FD/DARaf:ER than FD/DB-Raf:ER cells, higher levels of DRaf:ER kinase activity were observed in FD/DBRaf:ER than in FD/DA-Raf:ER cells. Very low levels of DB-Raf:ER protein were observed in FD/DBRaf:ER cells. Even though these cells had low levels of the DB-Raf:ER they expressed high levels of Raf kinase activity, most likely due to the enhanced activity level of the B-Raf kinase.
A comparison of the levels of DRaf:ER kinase activities present in the three dierent DRaf:ER infected FD cells was performed. The rank order of kinase activity was FD/DB-Raf:ER (46)4FD/DRaf-1:ER (26)4FD/DA-Raf:ER (16). This order is consistent with the observed strengths of the dierent Raf kinases published by others (Pritchard et al., 1995) .
As a control the levels of DRaf:ER mediated Raf activity were examined in cytokine-dependent FDC-P1 cells infected with the empty retroviral vector. No DRaf:ER protein or kinase activity was detected in the FDC-P1 cells that were infected with an empty retroviral viral vector (FD/pBP3) (Figure 1d) .
In order to determine if the activity of the downstream target of DRaf:ER, MEK-1, was also increased as a result of the DRaf:ER activation, endogenous MEK-1 was immunoprecipitated with an anti-MEK-1 antibody and MEK assays were performed. MEK-1 activity was also induced in FD/DRaf:ER cells as a result of ectopic activation of Raf molecules ( Figure  1a ± c). MEK-1 activity was also induced after IL-3 treatment. As a control, the level of MEK-1 protein used in the immunoprecipitations was determined by probing the kinase assay with an aMEK-1 antibody.
The protein level of endogenous MEK-1 remained relatively constant and was not increased due to the activation of DRaf:ER.
Cell proliferation induced by ectopic activation of DRaf:ER
The eects of the dierent Raf genes on cell proliferation and cell cycle progression were determined. After 24 h of cytokine or b-estradiol deprivation, the percentage of cells in S phase decreased signi®cantly which resulted in a G 1 arrest in all three FD/DRaf:ER lines (Figure 2a There was a lag phase period of more than 12 h before the cells suddenly progressed into the S phase at day 1 (Figure 2a ± d) . The increase of S phase was higher in cells treated with b-estradiol than with IL-3 (Figure 2a ± c) . These Raf-responsive cells were previously maintained in estradiol-supplemented medium and they may have adjusted their signaling pathway to quickly and eciently response to b-estradiol. The extent of increase of cells in S phase after b-estradiol addition is much higher in FD/DRaf-1:ER and FD/ DA-Raf:ER cells (i.e. between 30 and 40%) than in FD/DB-Raf:ER cells (approximately 20%). FD/pBP3 cells were only induced to enter S phase when they were treated with IL-3 ( Figure 2d ). The increase of cells in S phase induced by DRaf:ER activation (shown in Figure 2 ) was mainly due to the decrease of cells in G 1 phase. There was a transient decrease of cells in Figure 1 Eects of b-estradiol and IL-3 on Raf and MEK activities in Raf-responsive cells. One hundred mg of protein lysates were immunoprecipitated with an aER or aMEK-1 Ab. Raf and MEK assays were performed on aER or aMEK-1 immunoprecipitated proteins. The kinase blots were subsequently immunoprecipitated with aER and aMEK-1 antibodies to determine the protein levels of DRaf:ER and MEK-1. Since only Raf or MEK-1 and the proteins associated with them were precipitated, no housekeeping proteins could be used as an internal control for loading. However, 50 mg of the same cell lysates were used in Western immunoblotting with aactin Ab to con®rm the protein amount used in the kinase assay. Furthermore, these kinase assays have been performed three times and similar results were observed. (a) FD/DRaf-1:ER, (b) FD/DA-Raf:ER, (c) FD/DBRaf:ER, and (d) FD/pBP3 (IL-3) pool. At least two dierent clones from each type of DRaf:ER infected cells were examined and similar results were observed. 71: time when cultures were set up; 0: after 24 h of b-estradiol/IL-3 deprivation and before the addition of b-estradiol/IL-3 G 2 /M phase followed by an increase in FD/DRaf:ER cells (data not shown). Even though the DRaf:ER constructs were shown to induce GM ± CSF expression in FD/DRaf:ER cells , the induction of G 1 progression did not appear to be the result of autocrine GM ± CSF expression since entry into S phase occurred over a similar time period in cells treated with IL-3 or b-estradiol and before the synthesis of GM ± CSF (data not presented).
After 24 h of starvation, there were few dead cells as the cell viability was between 85 and 95%. When the cells were cultured with either b-estradiol or IL-3, the cell viability was above 95%. Interestingly, when cellular proliferation was examined, only the FD/ DRaf-1:ER ( Figure 2e ) and FD/DA-Raf:ER ( Figure  2f ) cells proliferated in response to DRaf:ER activation. Even though a moderate increase in S phase cells was observed in the FD/DB-Raf:ER population, these cells gradually died ( Figure 2g ). Neither b-estradiol nor IL-3 were able to rescue FD/DB-Raf:ER cells from undergoing apoptosis after they had been cultured in these assay conditions. Moreover empty vector infected cells only proliferated in response to IL-3.
The normal doubling time of the parental FDC-P1 cells when cultured in IL-3-containing medium is approximately 26.5 h. When cultured in an optimal amount of b-estradiol (500 nM, Hoyle et al., 2000) , FD/DRaf-1:ER, FD/DA-Raf:ER and FD/DB-Raf:ER cell clones had similar doubling times, i.e 27.3+1.2 h for FD/DRaf-1:ER, 25.9+2.0 h for FD/DA-Raf:ER and 24.1 h for FD/DB-Raf:ER. There were no signi®cant dierences in the lengths of the overall cell cycle when these cells were grown in the optimal condition. However, after 24 h of starvation, there was a signi®cant change in the length of the overall cell cycle as shown in Figure 2 . After 24 h of starvation from b-estradiol and IL-3, the cell cycle promoting machinery was shut down as witnessed by the downregulation of cyclins and Cdks in these cells. It takes sometime for the cells to synthesize those important cell cycle regulatory proteins. We believe that is why there was a prolonged cell doubling time after the starvation observed.
Effects of Raf activation on cell cycle regulatory protein expression
To determine the eects of Raf on cell cycle regulatory protein expression, the levels of cyclins (cyclin A, D, and E), Cdks (Cdk2 and Cdk4) (Figure 3 ), Cdk inhibitors (p21 Cip1 and p27 Kip1 ) and the proto-oncogene c-Myc (Figure 4) were determined by Western immunoblotting analysis. The levels of the G 1 /S cyclins including cyclin D, cyclin E, and cyclin A, and the G 1 /S Cdks including Cdk4 and Cdk2 were upregulated upon activation of DRaf:ER or stimulation by IL-3 (Figure 3a ± c) . In both FD/DRaf-1:ER and FD/DARaf:ER cells, the induction of these important cell cycle regulatory proteins were generally both more rapidly and to a higher degree when the cells were treated with b-estradiol than when the cells treated with IL-3 ( Figure  3a and b). This result was in accordance with the results observed with proliferation in Figure 2 . As a control, the levels of these proteins were examined in emptyvector infected cells. In FD/pBP3 cells, these proteins were only induced when the cells were treated with IL-3 (Figure 3d ). Even though the DRaf:ER constructs have been reported to induce GM-CSF expression in FD/ DRaf:ER cells , the induction of G 1 progression did not appear to be a result of autocrine GM ± CSF because b-estradiol and IL-3 induced entry into S phase at similar times.
Interestingly, an inverse expression pattern of the two Cip/Kip family proteins, p21
Cip1 and p27 Kip1 was observed in FD/DRaf:ER cells (Figure 4) . That is when the cells were induced to exit the cell cycle, induction of p27 Kip1 was observed. In contrast, when the cells were stimulated to enter the cell cycle, the levels of p21 
Assembly of p21
Cip1 with Cdk4/cyclin D complexes Precipitated Cdk2 and Cdk4 complexes were tested for their kinase activity using histone H1 as a substrate for Cdk2 and GST-pRb as the substrate for Cdk4 ( Figure  5 ). The total kinase reaction was then resolved on denaturing polyacrylamide gels and transferred to PVDF membranes. Cdk kinase activity was determined by the intensity of the phosphorylated substrate band on the autoradiographs. The membranes were then blotted with antibodies against Cdk and cyclin to Cip1 was associated with the activated Cdk4/cyclin D complex.
Discussion
In NIH3T3 murine ®broblast cells, only activation of the weakest DRaf:ER construct, i.e. DA-Raf:ER, induced cell cycle progression. Activation of either DRaf-1:ER or DB-Raf:ER lead to G 1 arrest which was associated with p21
Cip1 induction (Pritchard et al., 1995; Woods et al., 1997) . Similar results were also observed by Sewing et al. (1997) . They employed a dierent ectopically-inducible Raf system, DRaf:AR in which DRaf activity could be activated by androgens such as testosterone or the more eective synthetic testosterone analog R1881 (Sewing et al., 1997) . They observed that a strong Raf signal induced by R1881 lead to a p21 Cip1 -mediated G 1 arrest. However, when the DRaf activity was moderately induced by the less eective natural testosterone, the cells underwent proliferation. Together these results indicate that in murine ®broblast cells a potent Raf signal may lead to a p21 Cip1 -mediated cell cycle arrest instead of cell proliferation while only moderate Raf activity is necessary for cell proliferation.
In our studies, we observed that DRaf:ER activities in the infected FDC-P1 hematopoietic cells were in the following order: FD/DB-Raf:ER (46)4FD/DRaf-1:ER (26)4FD/DA-Raf:ER (16). Interestingly, entry into S phase, which led to cell proliferation, was only observed in FD/DRaf-1:ER and FD/DA-Raf:ER cells upon Raf activation. Even though some FD/DBRaf:ER cells entered S phase, they gradually died. This result is in agreement with the previous observations that only moderate Raf activation is needed for G 1 progression and cell proliferation (Pritchard et al., 1995; Sewing et al., 1997) . Cip1 with the kinase complexes. The cells were grown under the indicated conditions and then cell extracts were made. Cdk2 and Cdk4 kinase assays were performed as described in Materials and methods. The kinase blots were subsequently probed with anti-Cdk2, Cdk4, cyclin D, cyclin E, p21 Cip1 and p27
Kip1 antibodies. This experiment was performed three times and similar results were observed (Muszynski et al., 1995; Pritchard et al., 1995; Marias et al., 1997) . A-Raf and Raf-1 behave in a more similar fashion than B-Raf (Fabian et al., 1993; Marias et al., 1995 Marias et al., , 1997 Pritchard and McMahon, 1997; Vossler et al., 1997; Hagemann and Rapp, 1999; Rosario et al., 1999) . In our studies, we observed that after 24-h of b-estradiol deprivation, ectopic activation of either Raf-1 or A-Raf were able to induce cell proliferation. However, in FD/ DB-Raf:ER cells, an apoptosis signal was already triggered during the starvation period and neither activation of B-Raf nor IL-3-induced signaling were able to rescue the cells. It is not yet clear if the dierent results observed among these three dierent FD/ DRaf:ER clones were caused simply by the varying intensities of Raf kinase activity or the dierent functions of Raf-1, A-Raf and B-Raf.
In both FD/DRaf-1:ER and FD/DA-Raf:ER cells, the proliferative responses were more signi®cant in cells treated with b-estradiol than cells treated with IL-3. This was re¯ected in the higher levels of cyclin A, D, and E and Cdk2 and Cdk4 expression as well as a stronger upregulation of p21
Cip1 and a faster downregulation of p27
Kip1 . Since DRaf:ER infected cells were cultured constantly in medium supplemented with bestradiol and lacking exogenous IL-3, the cells likely adapted the high endogenous DRaf activity which then became the major signaling pathway responsible for cell proliferation and prevention of apoptosis.
Increased Cdk expression in proliferating cells, similar to what we observed in FDC-P1 cells induced by growth factors and Raf, has been observed in murine ®broblasts, macrophages (Matsushime et al., 1994) , embryonic stem cells (Tsutsui et al., 1999) ; rat ®broblast cells (Mateyak et al., 1999) ; human umbilical vein cord cells (Hermeking et al., 2000) and lymphoblastoid cells (Pajic et al., 2000) . The mechanisms for this proliferation-associated Cdk induction are not clear but it is most likely through the action of transcription factors induced by growth factors. Recently it has been shown that Cdk4 induction in proliferating cells is mediated through the transcription factor c-Myc. Cdk4 has been identi®ed as a target gene of c-Myc. c-Myc can induce a rapid increase in Cdk4 mRNA levels through four highly conserved c-Myc binding sites within the Cdk4 promoter region (Hermeking et al., 2000) . The activated Raf/MEK/ ERK pathway has been shown to induce c-Myc activity (Chuang and Ng, 1994; Gupta and Davis, 1994; Alexandrov et al., 1997; Zou et al., 1997; . Moreover, direct binding of Raf-1 and ERK2 to the N-terminal domain of c-Myc, which activates c-Myc activity, has been observed (Gupta and Davis, 1994; Alexandrov et al., 1997 (Xiong et al., 1993; Chen et al., 1995 Chen et al., , 1996 Harper et al., 1995; Luo et al., 1995; Nakanishi et al., 1995; Lin et al., 1996; Poon et al., 1996; Cai and Dynlacht, 1998) . They dier from the other Cdk inhibitor gene family INK4 in that they harbor both the Cdk and cyclin binding sites (Chen et al., 1995 (Chen et al., , 1996 Luo et al., 1995; Nakanishi et al., 1995; Lin et al., 1996) . The Cip/Kip family display a broad target spectrum as they bind with both G 1 and S phase Cdk/cyclin complexes and inhibit their function of phosphorylating RB and other pocket proteins (Xiong et al., 1993; Harper et al., 1995; Poon et al., 1996; Cai and Dynlacht, 1998) . This results in a G 1 arrest and a block in cell proliferation. Surprisingly, association with p21
Cip1 does not necessary inhibit the activity of Cdk/cyclin complexes since p21
Cip1 is present in both active and inactive forms of Cdk/cyclin complexes (Zhang et al., 1994) . Recent evidence even indicated that p21
Cip1 and p27 Kip1 have very dierent eects regarding the regulation of Cdk2/cyclin E or Cdk4/ cyclin D activity. They function as a Cdk-inhibitor when complexed with Cdk2/cyclin E, but as an activator when complexed with Cdk4/cyclin D. Cheng et al. (1999) have shown that in the primary mouse embryonic ®broblast cells that lack genes encoding both p21
Cip1 and p27 Kip1 , signi®cantly less Cdk4/cyclin D complexes were assembled, even though the cells express a comparable amount of cyclin D and Cdk4 as the wild-type cells. When the total protein lysates from wild-type mouse embryonic ®broblasts were immunodepleted of both p21
Cip1 and p27 Kip1 , the Cdk4 kinase activity was also completely depleted (Cheng et al., 1999) . These results suggest that both p21
Cip1 and p27 Kip1 function as activators for the Cdk4/ cyclin D assembly and therefore stimulate Cdk4 activity. In contrast, the assembly of Cdk2/cyclin E was actually enhanced in the p21 7/7 , p27 7/7 cells, indicating the negative regulatory role of Cip/Kip genes on the Cdk2 activity. LaBaer et al. (1997) found that the weak Cdk4/cyclin D assembly in wild-type epithelial cells was signi®cantly enhanced by the addition of p21
Cip1 or p27 Kip1 both in vitro and in vivo. Moreover, the complex assembly occurred in parallel to an increase in Cdk4 kinase activity (LaBaer et al., 1997) . Furthermore, the three Cip/Kip inhibitors can target the Cdk4/cyclin D complexes into the nucleus. Taking together, it was hypothesized that the functions of Cip/Kip proteins are to promote the assembly of the G 1 phase Cdk4/cyclin D complexes, target them into the nucleus and to inhibit the S phase Cdk2/cyclin E assembly and activity.
Our results indicate that activation of DRaf:ER could lead to a downregulation of p27 Kip1 and an upregulation of p21
Cip1 accompanied by G 1 progression in FD/DRaf-1:ER, FD/DA-Raf:ER and even FD/DBRaf:ER cells. This ®nding is interesting because it (Baldassarre et al., 1999; Estanyol et al., 1999; Morisset et al., 1999; Nakanishi et al., 1999) . We were able to detect the assembly of Cdk4, cyclin D and p21
Cip1 into a complex. Moreover, no binding between p21
Cip1 with Cdk2/cyclin E or p27
Kip1 with either Cdk4/cyclin D or Cdk2/cyclin E was observed in our cells. Furthermore, the increased binding between p21
Cip1 and Cdk4/cyclin D complexes in both b-estradiol and IL-3 treated FD cells were in accordance with the increased Cdk4 kinase activity. Our results suggested that in proliferation induced by either DRaf:ER or IL-3, p21
Cip1 regulated the activity of Cdk4 by directly binding with it, most likely to stabilize its conformation and ensure its activity as was suggested by other laboratories (LaBaer et al., 1997; Cheng et al., 1999) . However, p21
Cip1 did not execute the proposed inhibitory function on the Cdk2 since no binding between them was observed. The fact that there was no association between p27 Kip1 and either Cdk2 or Cdk4 suggested that at least in our model system, p27
Kip1 has little or no direct function regulating the activities of either Cdk2 or Cdk4.
The regulatory roles of p53 on p21 Cip1 expression have been well established. p21
Cip1 can be transcriptionally upregulated by the p53 protein, and is the primary mediator for the p53-dependent G 1 arrest that occurs following DNA damage (El-Deiry et al., 1993; Macleod et al., 1995; Issacs et al., 1997; Kim, 1997; Resnick-Silverman et al., 1998) . However, induction of p21 Cip1 does not always require p53 expression as p53-independent pathways of p21
Cip1 induction have been observed (Woods et al., 1997; Xiao et al., 1997; Moustakas and Kardassis, 1998; Beier et al., 1999) . Among them, one alternate pathway for p21 Cip1 induction is believed to be mediated through the Raf/ MEK/ERK signal pathway (Woods et al., 1997; Beier et al., 1999) . We were unable to detect any wild-type p53 in FDC-P1 cells. However, we did detect wild-type p53 in the p53 +/7 human hematopoietic TF-1 line (data not shown). Therefore, the upregulation of p21 Cip1 we observed in our studies is most likely due to the activation of Raf/MEK/ERK pathway and is p53-independent.
The regulation of p27 Kip1 expression is not yet clear. However, the transcription factor c-Myc is believed to be involved. In the Rat1 ®broblast cell line, the cell cycle arrest caused by ectopic p27
Kip1 expression was abrogated by activation of c-Myc (Vlach et al., 1996) . Furthermore, ®broblast cells carrying a homozygous null mutation of c-Myc have elevated p27
Kip1 levels (Mateyak et al., 1999) . However, since an E box, the DNA binding site recognized by transcription factor cMyc, was not found in the promoter region of p27 Kip1 , it was hypothesized that c-Myc does not regulate p27
Kip1 expression through direct transcriptional modulation. Downregulation of p27
Kip1 level caused by cMyc could be the result of Cdk2 activation induced by DRaf:ER since it has been shown that activated Cdk2 can directly phosphorylate p27
Kip1 (MuÈ ller et al., 1997; Shea et al., 1997) . The phosphorylated p27
Kip1 was then degraded through the ubiquitin-conjugating enzymes Ubc2 and Ubc3 (Pagano et al., 1995) .
Most of the studies previously performed for elucidation of the Ras/Raf/MEK/ERK pathway were with NIH3T3 ®broblast cells. Even though these studies have provided critical information regarding the Ras/ Raf/MEK/ERK pathway, they may or may not provide sucient information for understanding the roles of Ras/Raf/MEK/ERK pathway in other cell systems. It is important to use the hematopoietic cells as models to study the Ras/Raf/MEK/ERK pathway and tumorigenesis especially since Ras mutations occur frequently in human cancers that arise from hematopoietic cells but not ®broblasts (Bos, 1989; Shields et al., 2000) . Even though p21
Cip1 upregulation and p27 Kip1 downregulation after Raf activation have also been demonstrated in some NIH3T3 cell clones (Pritchard et al., 1995; Woods et al., 1997; . It was suggested that both molecules function as Cdk2 inhibitors and p21
Cip1 elevation, induced only by potent Raf activation, i.e. Raf-1 or B-Raf, was actually associated with G 1 arrest in NIH3T3 cells. We found a very dierent results in hematopoietic cells. Neither p21
Cip1 nor p27 Kip1 bind to Cdk2/cyclin E complexes and inactivate their kinase activity. Moreover we found that p21
Cip1 induced by Raf activation speci®cally bound with Cdk4/cyclin D complexes and this binding was associated with Cdk4 activation. However, similar results were not found with p27
Kip1 and Cdk4/cyclin D indicating the dierent eects of these two Cdk inhibitors. The association of p21
Cip1 binding with the increased Cdk4 kinase activity is in agreement with the recent ®ndings which suggested that p21
Cip1 may have a positive regulatory role in Cdk4/cyclin D complexes (Cheng et al., 1999; Sherr and Roberts, 1999) .
In summary, our studies demonstrated that even though all three DRaf:ER constructs were able to induce G 1 progression in murine hematopoietic FDC-P1 cells, only the ones with moderate DRaf activation, i.e. DRaf-1:ER and DA-Raf:ER, lead to cell proliferation. In contrast, cells infected with DB-Raf:ER gradually died after 24 h of starvation. The cell cycle progression induced by DRaf activation is associated with the upregulation of cyclin A, cyclin D, cyclin E, Cdk2 and Cdk4. DRaf activation lead to the downregulation of p27
Kip1
, which was associated with the upregulation of the molecule that is hypothesized to regulate its degradation, c-Myc. Although both p21 Cip1 and p27
Kip1 have been suggested to bind with Cdk4/ cyclin D complexes to activate its activity and also to bind with Cdk2/cyclin E complexes to inhibit its activity, we did not detect these associations in our studies. In contrast, we observed that p21
Cip1 was induced by DRaf activation and would speci®cally bind with the Cdk4/cyclin D complexes. This binding was in accordance with the activation of Cdk4 kinase activity. These results document that p21
Cip1 is upregulated in Raf-mediated signal transduction and associated with Cdk4/cyclin D complexes in hematopoietic cells.
Materials and methods
Cell culture
Murine hematopoietic FDC-P1 cells and the DRaf:ERinfected FDC-P1 cell clones were maintained in a humidi®ed 5% CO 2 incubator with Dulbecco's modi®ed medium (DMEM) supplemented with 5% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA, USA) and either IL-3 or bestradiol as indicated. FD/pBP3 cells are an IL-3-dependent pool obtained after infecting FDC-P1 cells with the empty retroviral vector pBP3puro in which the DRaf:ER genes are contained. IL-3-dependent FDC-P1 parental cells and FD/ pBP3 cells were cultured in DMEM and 5% FBS which was supplemented with 10% clari®ed WEHI-3B supernatant, which served as a source of IL-3. Five hundred nM bestradiol was added to the DMEM+5% FBS medium to ectopically activate the DRaf:ER fusion protein in the bestradiol-responsive FD/DRaf:ER cells. This was determined to be the optimal b-estradiol concentration to induce Raf activity . All chemicals were purchased from Sigma (St. Louis, MO, USA) unless otherwise indicated.
FACS cell cycle analysis and cell count
Exponentially growing cells (1 ± 3610 6 cells/ml) were starved in phenol-red free DMEM medium containing 5% FBS for 24 h before the addition of 10% IL-3 or 500 nM b-estradiol. At 12-h intervals for 2 days, cellular proliferation was determined using the Trypan blue exclusion method. At each time point, approximately 1 ± 3610 6 cells were washed and ®xed with 70% ethanol for the FACS cell cycle analysis. Aliquots of the cells were also used for protein lysates.
1 ± 3610 6 cells were collected by centrifugation after dierent intervals of incubation in the presence of either IL-3 or b-estradiol and washed twice with PBS before being ®xed with 70% ethanol for 12 h. Fixed cells were washed again with PBS containing 1% bovine serum albumin (BSA) and then stained with a propidium iodide solution in the dark for 30 min. The propidium iodide solution contains 50 mg/ml propidium iodide (Roche Diagnostics, Indianapolis, IN, USA), 250 mg/ml RNase (Roche Diagnostics) and 0.1% Triton X-100. Cells were passed through a 1-ml syringe with a 25G 5/8'' needle to dissociate cell clumps. Cellular DNA content was then analysed by quantifying the¯uorescence of propidium iodide-stained DNA with a Becton Dickinson FACScan. The percentages of cells in the dierent phases of cell cycle were analysed using Mod®t 5.02 cell cycle analysis software.
Cellular protein extract preparation
Cells were collected by centrifugation and washed twice with PBS. The cell pellet was then lysed in Gold lysis buer (GLB) containing 20 mM Tris (pH 7.5), 137 mM NaCl, 5 mM ethylenediamine-tetraacetic acid (EDTA), 1% (v/v) Triton X-100, 15% (v/v) glycerol, 1 mM phenylmethylsulfonyl uoride, 1 mg/ml leupetin, 1 mg/ml aprotinin, 1 mM sodium orthovanadate, 1 mM ethylene glycol-bis(b-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), 10 mM sodium¯uoride, 1 mM tetrasodium pyrophosphate, and 0.1 mM b-glycerophosphate. Lysates were clari®ed by centrifugation at 15 000 g for 15 min and the total protein was quanti®ed by bicinchoninic acid method (Pierce, Rockford, IL, USA).
Raf and MEK assays
In the Raf kinase assays, 100 mg of cell lysates were incubated with anti-ER antibody (Santa Cruz Biotechnology, SCB, Santa Cruz, CA, USA) for 1 h and then immunoprecipitated with protein-A sepharose beads overnight. The immunoprecipitates were washed three times with lysis buer and then incubated at 308C for 30 min in 15 ml kinase reaction solution containing 1 mM MnCl 2 , 1 mM dithiothreitol (DTT), 50 mM ATP, 10 mCi [g-32 P]ATP and 0.5 ml of puri®ed Raf kinase substrate, GST-MEK-1 (Upstate Biotechnology (UBI), Lake Placid, NY, USA). In the MEK assays, cell lysates were immunoprecipitated with anti-MEK-1 antibody (SCB), and the kinase assay was performed in a similar reaction solution except that the Raf substrate was replaced with the puri®ed MEK kinase substrate, GST-ERK2 (UBI, USA). The reaction mixture was electrophoresed through an 8 ± 10% polyacrylamide gel, and then transferred to a polyvinylidene diluoride (PVDF) membrane (Millipore, New Bedford, MA, USA). Autoradiography was performed by exposing an X-ray ®lm (Kodak, Rochester, MA, USA) to the kinase reaction on the PVDF membrane. The levels of DRaf:ER or MEK-1 proteins were determined by immunoblotting the PVDF membrane with the anti-ER or anti-MEK-1 antibody respectively.
Cdk2 and Cdk4 kinase assays
Four hundred mgs of cellular proteins were immunoprecipitated with anti-Cdk2 (SC-163) (SCB) or anti-Cdk4 (SC-260) antibodies and protein-A sepharose beads overnight. The immunoprecipitates were incubated for 30 min at 308C in 15 ml of kinase reaction solution containing 50 mM HEPES (pH 8.0), 10 mM MgCl 2 , 1 mM DTT, 2.5 mM EGTA, 10 mM b-glycerolphosphate, 50 mM ATP and 10 mCi [g-32 P]ATP. In the Cdk2 kinase assay, 5 mg of histone H1 (Roche Diagnostics) was added as the kinase substrate; in the Cdk4 kinase assay 1.5 mg of GST-pRb (SCB) was added as kinase substrate. The reaction mixture was electrophoresed on a 15% polyacrylamide gel, and transferred to a PVDF membrane. Autoradiography was performed by exposing an X-ray ®lm to the kinase blot. The levels of proteins that were coimmunoprecipitated with the Cdks were determined by immunoblotting the membrane with appropriate antibodies.
Western blot analysis
Fifty mg of cellular proteins were resolved on 15% SDS polyacrylamide gels and then transferred to PVDF membranes. The membranes were ®rst incubated with primary antibodies against cyclins, Cdks, or Cdk inhibitors and then incubated with horseradish peroxidase-linked secondary antibody or protein-A. All the antibodies were purchased from SCB: Cdk2 (SC-163), Cdk4 (SC-260), cyclin A (SC-751), cyclin D1 (SC-8396), P27 Kip1 (SC-528), c-Myc (SC-788), ER (SC-543), and MEK (SC-219), with the exception of p21 Cip1 (WAF1 (Ab-5)) which was purchased from CalbiochemNovabiochem Corporation (San Diego, CA, USA). The Western blot procedure was performed as described previously (McCubrey et al., 1998; Hoyle et al., 2000; . The speci®c protein bands were visualized by an enhanced chemiluminescence assay (Kodak, Rochester, NY, USA).
